Safety concerns included uncharacterized immunogenicity (the risk that injected peptides trigger immune reactions), inadequate impurity and endotoxin testing in available raw material, the unresolved free base versus acetate salt form distinction, and, for BPC-157 specifically, an angiogenesis mechanism that raises theoretical cancer-risk concerns for certain patient populations
Possible temporary reactions include: Mild soreness at the injection site Nausea, headache or dizziness for a day or two Occasional minor bruising Serious side effects are very rare
Ideal candidates are adults seeking metabolic support and cellular energy optimization
Regulatory peptides , 160 (1-3), 2632
Reconstitution B: 10 mg vial + 1 mL BAC water (10 mg/mL) half the volume per dose
The information in this article is educational in nature and does not constitute medical advice